MedAdvisor, Zuellig Pharma in JV to market medication management solutions in Asia

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture (JV) ZP MedAdvisor (ZPM) to commercialise MedAdvisor’s platform across Asia. Read more at The Business Times.

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture ZP MedAdvisor to commercialise MedAdvisor’s platform across Asia.

ZPM has signed a software licence agreement for its medication management solutions on an exclusive basis for eight key markets - Singapore, Thailand, Indonesia, South Korea, Taiwan, Hong Kong, the Philippines and Malaysia.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 15. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

South-east Asia stocks end weaker as Trump threat jolts markets, Singapore divesBENGALURU — South-east Asian stocks closed lower on Monday (May 6) after US President Donald Trump threatened to hike tariffs on Chinese goods this week, rekindling trade tensions between Washington and Beijing, with Singapore leading the losses in the region.
Sumber: TODAYonline - 🏆 1. / 99 Baca lebih lajut »